These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 11532423)

  • 1. Is a proliferation index of cancer cells a reliable prognostic factor after hepatectomy in patients with colorectal liver metastases?
    Weber JC; Nakano H; Bachellier P; Oussoultzoglou E; Inoue K; Shimura H; Wolf P; Chenard-Neu MP; Jaeck D
    Am J Surg; 2001 Jul; 182(1):81-8. PubMed ID: 11532423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of surgical margin on type of recurrence after liver resection for colorectal metastases: a single-center experience.
    Nuzzo G; Giuliante F; Ardito F; Vellone M; Giovannini I; Federico B; Vecchio FM
    Surgery; 2008 Mar; 143(3):384-93. PubMed ID: 18291260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histopathological prognostic factors influencing long-term prognosis after surgical resection for hepatic metastases from colorectal cancer.
    Nagashima I; Oka T; Hamada C; Naruse K; Osada T; Muto T
    Am J Gastroenterol; 1999 Mar; 94(3):739-43. PubMed ID: 10086660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatic resection for colorectal metastases: analysis of prognostic factors.
    Ambiru S; Miyazaki M; Isono T; Ito H; Nakagawa K; Shimizu H; Kusashio K; Furuya S; Nakajima N
    Dis Colon Rectum; 1999 May; 42(5):632-9. PubMed ID: 10344686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fas/CD95 signaling rather than angiogenesis or proliferative activity is a useful prognostic factor in patients with resected liver metastases from colorectal cancer.
    Onodera H; Mori A; Nagayama S; Fujimoto A; Tachibana T; Yonenaga Y; Tsuruyama T
    Int J Colorectal Dis; 2005 Nov; 20(6):477-84. PubMed ID: 15846499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical features and prognosis in hepatectomy for colorectal cancer with centrally located liver metastasis.
    Kuo IM; Huang SF; Chiang JM; Yeh CY; Chan KM; Chen JS; Yu MC
    World J Surg Oncol; 2015 Mar; 13():92. PubMed ID: 25889950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pre- and postoperative carcinoembryonic antigen determinations in hepatic resection for colorectal metastases. Predictive value and implications for adjuvant treatment based on multivariate analysis.
    Hohenberger P; Schlag PM; Gerneth T; Herfarth C
    Ann Surg; 1994 Feb; 219(2):135-43. PubMed ID: 8129484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic factors and survival after resection of colorectal liver metastasis in the era of preoperative chemotherapy: an 11-year single-centre study.
    John SK; Robinson SM; Rehman S; Harrison B; Vallance A; French JJ; Jaques BC; Charnley RM; Manas DM; White SA
    Dig Surg; 2013; 30(4-6):293-301. PubMed ID: 23969407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Post-chemotherapeutic CEA and CA19-9 are prognostic factors in patients with colorectal liver metastases treated with hepatic resection after oxaliplatin-based chemotherapy.
    Sakamoto Y; Miyamoto Y; Beppu T; Nitta H; Imai K; Hayashi H; Baba Y; Yoshida N; Chikamoto A; Baba H
    Anticancer Res; 2015 Apr; 35(4):2359-68. PubMed ID: 25862901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical relevance of transforming growth factor alpha, epidermal growth factor receptor, p53, and Ki67 in colorectal liver metastases and corresponding primary tumors.
    De Jong KP; Stellema R; Karrenbeld A; Koudstaal J; Gouw AS; Sluiter WJ; Peeters PM; Slooff MJ; De Vries EG
    Hepatology; 1998 Oct; 28(4):971-9. PubMed ID: 9755233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinicopathological features and prognosis in resectable synchronous and metachronous colorectal liver metastasis.
    Tsai MS; Su YH; Ho MC; Liang JT; Chen TP; Lai HS; Lee PH
    Ann Surg Oncol; 2007 Feb; 14(2):786-94. PubMed ID: 17103254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liver metastases from colorectal cancer: present surgical approach.
    Cavallari A; Vivarelli M; Bellusci R; Montalti R; De Ruvo N; Cucchetti A; De Vivo A; De Raffele E; Salone M; La Barba G
    Hepatogastroenterology; 2003; 50(54):2067-71. PubMed ID: 14696466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Surgical resection of colorectal liver metastases: Gold standard for solitary and radically resectable lesions].
    Scheele J; Altendorf-Hofmann A; Stangl R; Schmidt K
    Swiss Surg; 1996; Suppl 4():4-17. PubMed ID: 8963836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pre-hepatectomy prognostic staging to determine treatment strategy for colorectal cancer metastases to the liver.
    Tanaka K; Shimada H; Fujii Y; Endo I; Sekido H; Togo S; Ike H
    Langenbecks Arch Surg; 2004 Oct; 389(5):371-9. PubMed ID: 15605168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resection of synchronous liver metastases from colorectal cancer.
    Fujita S; Akasu T; Moriya Y
    Jpn J Clin Oncol; 2000 Jan; 30(1):7-11. PubMed ID: 10770561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retrospective analysis of clinical and pathologic risk factors in liver resection for hepatic colorectal metastases.
    Zhou L; Zhag G; Tang T; Lian R; Wang W
    J Cancer Res Ther; 2013 Nov; 9 Suppl():S178-82. PubMed ID: 24516057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcome of surgical treatment of synchronous liver metastases from colorectal cancer.
    Taniai N; Yoshida H; Mamada Y; Matsumoto S; Mizuguchi Y; Suzuki H; Furukawa K; Akimaru K; Tajiri T
    J Nippon Med Sch; 2006 Apr; 73(2):82-8. PubMed ID: 16641532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Results of 136 curative hepatectomies with a safety margin of less than 10 mm for colorectal metastases.
    Elias D; Cavalcanti A; Sabourin JC; Pignon JP; Ducreux M; Lasser P
    J Surg Oncol; 1998 Oct; 69(2):88-93. PubMed ID: 9808511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is hepatectomy justified for patients with RAS mutant colorectal liver metastases? An analysis of 524 patients undergoing curative liver resection.
    Passot G; Denbo JW; Yamashita S; Kopetz SE; Chun YS; Maru D; Overman MJ; Brudvik KW; Conrad C; Aloia TA; Vauthey JN
    Surgery; 2017 Feb; 161(2):332-340. PubMed ID: 27592215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Recurrent colorectal liver metastases: who benefits from a second hepatic resection?].
    Konopke R; Volk A; Gastmeier J; Ehehalt F; Distler M; Saeger HD; Kersting S
    Zentralbl Chir; 2014 Apr; 139(2):226-34. PubMed ID: 23846538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.